Sfoglia per Autore
Idiopathic erythrocytosis: a germline disease?
2024 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
2024 Villa, M; Malighetti, F; Sala, E; Sharma, G; Arosio, G; Gemelli, M; Manfroni, C; Fontana, D; Cordani, N; Meneveri, R; Zambon, A; Piazza, R; Pagni, F; Cortinovis, D; Mologni, L
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape
2024 Fontana, D; Zambrotta, G; Scannella, A; Piazza, R; Gambacorti-Passerini, C
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients
2023 Fontana, D; Crespiatico, I; Crippa, V; Malighetti, F; Villa, M; Angaroni, F; De Sano, L; Aroldi, A; Antoniotti, M; Caravagna, G; Piazza, R; Graudenzi, A; Mologni, L; Ramazzotti, D
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review
2023 Fontana, D; Elli, E; Pagni, F; Piazza, R
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706)
2022 Bossi, E; Aroldi, A; Borin, L; Verga, L; Fontana, D; Cocito, F; Manghisi, B; Rindone, G; Cavalca, F; Ripamonti, A; Raggi, M; Malandrin, S; Cavallero, A; Antolini, L; Bonardi, D; Piazza, R; Gambacorti-Passerini, C
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution
2022 Fontana, D; Crippa, V; Bassi, G; D'Aliberti, D; Mauri, M; Spinelli, S; Mastini, C; Bombelli, S; Civettini, I; Guglielmana, V; Perego, R; Ramazzotti, D; Mologni, L; Piazza, R; Gambacorti Passerini, C
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis
2022 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Manghisi, B; Cavalca, F; Ripamonti, A; Brioschi, F; Palamini, S; Mottadelli, F; Ramazzotti, D; Piperno, A; Gambacorti Passerini, C; Piazza, R
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy
2022 Villa, M; Malighetti, F; Sharma, G; Arosio, G; Sala, E; Manfroni, C; Fontana, D; Cordani, N; Meneveri, R; Zambon, A; Piazza, R; Pagni, F; Cortinovis, D; Mologni, L
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience
2022 Steidl, C; Aroldi, A; Mologni, L; Crespiatico, I; Fontana, D; Mastini, C; Fumagalli, M; Perfetti, P; Borin, L; Valentini, C; Piazza, R; Gambacorti-Passerini, C
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution
2022 Ramazzotti, D; Angaroni, F; Maspero, D; Mauri, M; D’Aliberti, D; Fontana, D; Antoniotti, M; Elli, E; Graudenzi, A; Piazza, R
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia
2022 Gambacorti-Passerini, C; Nicolini, F; Larson, R; Aroldi, A; Fontana, D; Piazza, R; le Coutre, P; Antolini, L; Assouline, S
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models
2021 Sharma, G; Arosio, G; Villa, M; Mauri, M; Zappa, M; Magistroni, V; Ceccon, M; Redaelli, S; Crespiatico, I; Fontana, D; Mastini, C; Garbin, A; Lovisa, F; Mussolin, L; Piazza, R; Gambacorti Passerini, C; Mologni, L
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
2021 Fontana, D; Gambacorti Passerini, C; Piazza, R
Impact of ETNK1 somatic mutations on phosphoethanolamine synthesis, ROS production and DNA damage
2021 Fontana, D; Gambacorti Passerini, C; Piazza, R
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma
2021 Arosio, G; Sharma, G; Villa, M; Mauri, M; Crespiatico, I; Fontana, D; Manfroni, C; Mastini, C; Zappa, M; Magistroni, V; Ceccon, M; Redaelli, S; Massimino, L; Garbin, A; Lovisa, F; Mussolin, L; Piazza, R; Gambacorti Passerini, C; Mologni, L
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy
2020 Bossi, E; Aroldi, A; Brioschi, F; Steidl, C; Baretta, S; Renso, R; Verga, L; Fontana, D; Sharma, G; Mologni, L; Mussolin, L; Piazza, R; Gambacorti Passerini, C
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition
2020 Nucera, S; Fazio, G; Piazza, R; Rigamonti, S; Fontana, D; Gambacorti Passerini, C; Maitz, S; Rovelli, A; Biondi, A; Cazzaniga, G; Balduzzi, A
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation
2020 Diral, E; Mori, S; Antolini, L; Abruzzese, E; Le Coutre, P; Martino, B; Pungolino, E; Elena, C; Bergamaschi, M; Assouline, S; Di Bona, E; Gozzini, A; Andrade-Campos, M; Stagno, F; Iurlo, A; Pirola, A; Fontana, D; Petiti, J; Bonanomi, M; Crivori, P; Piazza, R; Fava, C; Gambacorti Passerini, C
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile